Seeing Is Believing
with an average price target of $16.95. This is a potential upside of $4.45 (35.6%) from yesterday's end of day stock price of $12.5.
POINT Biopharma Global's activity chart (see below) currently has 29 price targets and 22 ratings on display.
Analysts average stock forecasts to be materialized ratio is 35% with an average time for these price targets to be met of 75.5 days.
Most recent stock forecast was given by KEMP DOLLIVER from BROOKLINE on 21-Dec-2023.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$12.5
$27
1 years 9 months 13 days ago
(21-Dec-2023)
1/3 (33.33%)
$0.03 (0.24%)
5
Hold
$12.5
$17
1 years 11 months 10 days ago
(24-Oct-2023)
1/3 (33.33%)
$-0.16 (-1.26%)
55
Hold
$13
1 years 11 months 28 days ago
(06-Oct-2023)
2/2 (100%)
$3.73 (40.24%)
156
Hold
$12.5
$14
2 years ago
(04-Oct-2023)
2/3 (66.67%)
$0.1 (0.81%)
199
Hold
$22
2 years 1 days ago
(04-Oct-2023)
0/1 (0%)
$13.49 (158.52%)
What is PNT (POINT Biopharma Global) average time for price targets to be met?
Which analyst has the current highest performing score on PNT (POINT Biopharma Global) with a proven track record?
Which analyst has the most public recommendations on PNT (POINT Biopharma Global)?
Which analyst is the currently most bullish on PNT (POINT Biopharma Global)?
Which analyst is the currently most reserved on PNT (POINT Biopharma Global)?